377 MYLAN (Naproxen 250 mg)
Pill imprint 377 MYLAN has been identified as Naproxen 250 mg.
Naproxen is used in the treatment of back pain; sciatica; gout, acute; ankylosing spondylitis; muscle pain (and more), and belongs to the drug class nonsteroidal anti-inflammatory agents. Risk cannot be ruled out during pregnancy. Naproxen 250 mg is not a controlled substance under the Controlled Substance Act (CSA).
- 377 MYLAN
- 250 mg
- 10.00 mm
- Rx and/or OTC
- Drug Class:
- Nonsteroidal anti-inflammatory agents
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC):
- Inactive Ingredients:
- croscarmellose sodium
sodium lauryl sulfate
|NDC Code||Manufacturer / Repackager|
|51079-0793||UDL Laboratories Inc|
|66267-0151||Nucare Pharmaceuticals Inc (repackager)|
Note: Inactive ingredients may vary.
More about naproxen
- Naproxen enteric-coated tablets
- Naproxen suspension
- Naproxen sustained-release tablets
- Naproxen tablets and capsules
- Naproxen (Advanced Reading)
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.